EFCAB13 and myeloid sarcoma: Intriguingly, we observed a trend towards a down-regulation of the EFCAB13 transcript in MS in comparison with controls in six transcriptional assays from public GEO repository; it is thus tempting to speculate that a down-modulation of EFCAB13, partially associated with its genetic variants, may be involved in MS susceptibility.